Results 41 to 50 of about 1,952,025 (296)

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo, Weisi Dai, Jie Mao, Mei Ye, Xingshan Lu, Xiaocui Zhang   +5 more
wiley   +1 more source

Tricuspid regurgitation influences outcome after heart transplantation

, 2014
We investigated the correlation between tricuspid regurgitation (TR) and late survival, and its relation to bicaval (BC) and biatrial (BA) technique, after heart transplantation (HTx)
Wartig, Maria, Selimovic, Nedim,, Tesan, Sofie, Gäbel, Jakob,, Dellgren, Göran,, Holmberg, Erik,, Jeppsson, Anders,   +6 more
core   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa, Kyomi Kanaya, Kiyomi Aizawa, Masanori Onoki, Hirofumi Ozeki, Kazuko Suzuki, Ai Hayashi, Tomohiko Asamura   +7 more
wiley   +1 more source

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

FEBS Letters, EarlyView.
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta, Hari Baskar Balasubramanian, Amir Pasokh, Marietta Zille   +3 more
wiley   +1 more source

Heart transplantation in chagas cardiomyopathy

, 2022
Heart transplantation modifies the natural history of end-stage chronic Chagas cardiomyopathy and is currently established as a valuable therapeutic option.Patients with Chagas disease and heart transplantation require close and multidisciplinary follow ...
Favaloro, Liliana Ethel, Vigliano, Carlos   +1 more
core   +1 more source

Oritavancin in LVAD related infections - a chance for shortening therapy and improving outcomes

BMC Infectious Diseases
Background LVAD utility in heart failure patients is growing. Despite advancement in technology rates of LVAD- related infections remain high limiting outcomes. We aimed to assess the effectiveness and safety of oritavancin for LVAD-related Gram-positive
Marta Załęska-Kocięcka, Szymon Mielczarek, Piotr Góral, Kamil Marcinkiewicz, Katarzyna Byczkowska, Karina Zatorska, Justyna Cieślik, Karolina Paszyń, Aleksandra Tomaszek, Piotr Kołsut, Katarzyna Jóźwik-Plebanek, Jarosław Kuriata, Jarosław Szymański, Przemysław Leszek   +13 more
doaj   +1 more source

Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure

Cell Transplantation, 2019
Ventricular arrhythmias (VA) are of major concern in the field of cell therapy, potentially limiting its safety and efficacy. We sought to investigate the effects of CD34 + cell therapy on VA burden in patients with chronic heart failure (CHF).
Gregor Poglajen, Gregor Zemljič, Andraž Cerar, Sabina Frljak, Martina Jaklič, Vesna Androcec, Bojan Vrtovec   +6 more
doaj   +1 more source

Panoramic on Epigenetics in Coronary Artery Disease and the Approach of Personalized Medicine

Biomedicines, 2023
Epigenetic modifications play a fundamental role in the progression of coronary artery disease (CAD). This panoramic review aims to provide an overview of the current understanding of the epigenetic mechanisms involved in CAD pathogenesis and highlights ...
Marcello Bergonzini, Francesco Loreni, Antonio Lio, Marco Russo, Guglielmo Saitto, Antonio Cammardella, Francesco Irace, Corrado Tramontin, Massimo Chello, Mario Lusini, Antonio Nenna, Chiara Ferrisi, Federico Ranocchi, Francesco Musumeci   +13 more
doaj   +1 more source

Neonatal heart transplantation [PDF]

Annals of Cardiothoracic Surgery, 2018
Neonatal heart transplantation was developed and established in the 1980's as a durable modality of therapy for complex-uncorrectable heart disease. Patients transplanted in the neonatal period have experienced unparalleled long-term survival, better than for any other form of solid-organ transplantation.
Mohan, John, Leonard L, Bailey
openaire   +2 more sources

Identify New Genetic Variants on Chromosome 6 Associated with Mortality after Heart Transplantation

, 2020
PURPOSE: Graft failure in heart transplant recipients is still the leading cumulative cause of death, rejection related injuries likely being an important contributor.
Nilsson, J.,, Zar, G.,, Lund University., Vihinen, M.,   +3 more
core   +1 more source